Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Associations of Outdoor Fine Particulate Air Pollution and Cardiovascular Disease in 157 436 Individuals From 21 High-Income, Middle-Income, and Low-Income Countries (Pure): A Prospective Cohort Study Publisher Pubmed



Hystad P1, 2 ; Larkin A1 ; Rangarajan S2 ; Alhabib KF3 ; Avezum A4 ; Calik KBT5 ; Chifamba J6 ; Dans A7 ; Diaz R8 ; Du Plessis JL9 ; Gupta R10 ; Iqbal R11 ; Khatib R12, 13 ; Kelishadi R14 Show All Authors
Authors
  1. Hystad P1, 2
  2. Larkin A1
  3. Rangarajan S2
  4. Alhabib KF3
  5. Avezum A4
  6. Calik KBT5
  7. Chifamba J6
  8. Dans A7
  9. Diaz R8
  10. Du Plessis JL9
  11. Gupta R10
  12. Iqbal R11
  13. Khatib R12, 13
  14. Kelishadi R14
  15. Lanas F15
  16. Liu Z16
  17. Lopezjaramillo P17, 18
  18. Nair S19
  19. Poirier P20
  20. Rahman O21
  21. Rosengren A22
  22. Swidan H23
  23. Tse LA16
  24. Wei L24
  25. Wielgosz A25
  26. Yeates K26
  27. Yusoff K27, 28
  28. Zatonski T29
  29. Burnett R30
  30. Yusuf S2
  31. Brauer M31

Source: The Lancet Planetary Health Published:2020


Abstract

Background: Most studies of long-term exposure to outdoor fine particulate matter (PM2·5) and cardiovascular disease are from high-income countries with relatively low PM2·5 concentrations. It is unclear whether risks are similar in low-income and middle-income countries (LMICs) and how outdoor PM2·5 contributes to the global burden of cardiovascular disease. In our analysis of the Prospective Urban and Rural Epidemiology (PURE) study, we aimed to investigate the association between long-term exposure to PM2·5 concentrations and cardiovascular disease in a large cohort of adults from 21 high-income, middle-income, and low-income countries. Methods: In this multinational, prospective cohort study, we studied 157 436 adults aged 35–70 years who were enrolled in the PURE study in countries with ambient PM2·5 estimates, for whom follow-up data were available. Cox proportional hazard frailty models were used to estimate the associations between long-term mean community outdoor PM2·5 concentrations and cardiovascular disease events (fatal and non-fatal), cardiovascular disease mortality, and other non-accidental mortality. Findings: Between Jan 1, 2003, and July 14, 2018, 157 436 adults from 747 communities in 21 high-income, middle-income, and low-income countries were enrolled and followed up, of whom 140 020 participants resided in LMICs. During a median follow-up period of 9·3 years (IQR 7·8–10·8; corresponding to 1·4 million person-years), we documented 9996 non-accidental deaths, of which 3219 were attributed to cardiovascular disease. 9152 (5·8%) of 157 436 participants had cardiovascular disease events (fatal and non-fatal incident cardiovascular disease), including 4083 myocardial infarctions and 4139 strokes. Mean 3-year PM2·5 at cohort baseline was 47·5 μg/m3 (range 6–140). In models adjusted for individual, household, and geographical factors, a 10 μg/m3 increase in PM2·5 was associated with increased risk for cardiovascular disease events (hazard ratio 1·05 [95% CI 1·03–1·07]), myocardial infarction (1·03 [1·00–1·05]), stroke (1·07 [1·04–1·10]), and cardiovascular disease mortality (1·03 [1·00–1·05]). Results were similar for LMICs and communities with high PM2·5 concentrations (>35 μg/m3). The population attributable fraction for PM2·5 in the PURE cohort was 13·9% (95% CI 8·8–18·6) for cardiovascular disease events, 8·4% (0·0–15·4) for myocardial infarction, 19·6% (13·0–25·8) for stroke, and 8·3% (0·0–15·2) for cardiovascular disease mortality. We identified no consistent associations between PM2·5 and risk for non-cardiovascular disease deaths. Interpretation: Long-term outdoor PM2·5 concentrations were associated with increased risks of cardiovascular disease in adults aged 35–70 years. Air pollution is an important global risk factor for cardiovascular disease and a need exists to reduce air pollution concentrations, especially in LMICs, where air pollution levels are highest. Funding: Full funding sources are listed at the end of the paper (see Acknowledgments). © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND 4.0 license
Other Related Docs